Home Combat Arthritis Regeneron's Arthritis Drug Fails COVID-19 Trial

Regeneron's Arthritis Drug Fails COVID-19 Trial

Jul 06, 2020 comments off

Regeneron’s Arthritis Drug Fails COVID-19 Trial

Kevzara failed to help the most severely affected COVID-19 patients.

Read More…

You May Also Like

U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie – Reuters

Antibody levels higher after Moderna shot; Lilly arthritis drug used with steroid cuts death risk – Reuters

WHO-led trial to study three anti-inflammatory drugs for COVID-19 patients – Reuters India

Podiatrists debunk 12 feet myths

NIH starts study of COVID-19 booster shot in people with autoimmune diseases – Reuters

Pharma Stock Roundup: PFE's COVID Jab Full Approval by FDA, JNJ's Booster Data